New test could transform diagnosis and treatment of STIs
A new rapid test for sexually transmitted infections could soon transform on-the-spot diagnosis and treatment.
Birmingham-based Linear Diagnostics has secured £1 million in funding to develop the technology, which could deliver results in less than 20 minutes.
The funding comes from the NIHR Invention for Innovation programme and will support a three-year project to finalise the test and prepare it for clinical trials.
Dr Jean-Louis Duprey, head of research and development at Linear Diagnostics, said: "We are developing a near patient device that will overcome this conundrum."
The company is working with the NIHR HealthTech Research Centre and the North East Innovation Lab to deliver the project.
Dr Jana Suklan, senior methodologist at the HRC, said: "The NIHR HRC in Diagnostic and Technology Evaluation is delighted to be collaborating with the North East Innovation Lab to support Linear Diagnostics with their exciting technology.
"Our research involves analysing unmet needs, examining current practice and identifying the most promising point in the patient pathway for implementing the technology."
The test uses Linear's Exponential Amplification (EXPAR) technology, which detects bacterial DNA within minutes.
The company has focused on STIs such as Neisseria gonorrhoeae and Chlamydia trachomatis, where rapid diagnosis is essential to prevent further transmission and begin treatment immediately.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
18 minutes ago
- Hamilton Spectator
Saint Andrews doctor leans on collaborative model to move patients off waitlist
A Saint Andrews-based doctor has expanded her practice to include more health professionals in an effort to get more people in the community off the waitlist for primary care. Dr. Julie Levesque-Taylor operates out of the Wellness Centre in Saint Andrews – a clinic provided by the Town of Saint Andrews as part of an effort to provide accessible healthcare to residents. She moved from Manitoba about four years ago and said she noticed that many doctors were operating alone – meaning there is little room to see patients in a timely fashion or take on more patients over time. There are roughly 18,000 people in Zone 2 waiting to be matched with a primary care provider – which encompasses southwestern New Brunswick, according to Public Health. 'What it means is that you can't take on as many people because there's only so many hours and minutes in the day to be able to do all that work,' she said in an interview with CHCO-TV. Levesque-Taylor said it usually results in shorter visits or you don't get as in-depth an assessment. 'I noticed when I first got here that it's just not sustainable, or it's sustainable on a very small scale,' she said. 'We took on patients, and people came in, they called, they begged, they pleaded, (and) our staff listened … and then there came the heartbreaking moment where we have to start saying no.' So, Levesque-Taylor leaned into a model with proven success in Manitoba. She got funding through Family Medicine New Brunswick (FMNB), a program administered by the New Brunswick Medical Society (NBMS). 'The goal is to encourage physicians like myself to build primary care teams,' she said. New Brunswick Health Minister Dr. John Dornan said the FMNB was initiated several years ago, but didn't get much uptake so some adjustments were made. 'The practice is capitated, which means that the physician gets a certain amount of money for every patient that they take on and then there is monies that are applied or given to the physicians to hire additional healthcare staff, for example a nurse practitioner or nurse,' he said in an interview with The Courier. He said this is similar to the collaborative care model the government is expanding across the province, with the commitment for 30 clinics by 2030. Two clinics have been committed to St. Stephen in 2025 and Blacks Harbour in 2026. He explained collaborative care clinics must have digitized patient records, they must be dealing with a certain number of patients and seeing them within a reasonable amount of time. All things Levesque-Taylor's expanded model checks off the list. 'So, we know that when people work collaboratively, they are way more able to see more patients,' Dornan said, adding they ideally want clinics within a certain geographical area to see residents who live there. Levesque-Taylor said she aims to have everyone with the postal code beginning with E5B — within Saint Andrews — taken off the list. 'We've already started making phone calls, and we hope to take on an extra 400 patients,' she said. Dornan said the department is negotiating the details to help fund the clinic as a collaborative care clinic, adding it doesn't change the commitment it has made to the two other regions in Charlotte County. In March, Dornan said St. Stephen would have a collaborative care clinic by the end of the year. 'St. Stephen is one of those … We have already signed contracts with groups of people who are putting together these collaborative care clinics, so while not everyone has a clinic promised in the next year, yours is one of them,' he said in the legislative assembly in March. He said many people end up in the emergency departments of the Charlotte County and Saint John hospitals due to the lack of accessible primary care – and the work being undertaken by Levesque-Taylor is part of the overall solution. Ultimately, she hopes to recruit more doctors to Charlotte County. 'You should be able to go to your family health team home and to be able to have it planned in such a way that when the main doctor is away, there's someone there covering, and you can see your doctor,' she said. 'You don't have to go to the emergency room unless it's a life-or-limb.' The New Brunswick Medical Society (NBMS) said this new collaborative model is how physicians are being trained – and brings advantages for both patients and health care providers. 'Many of the existing team-based clinics in our province today exist because of innovative physicians, like Dr. Levesque Taylor, who have invested their own resources and time to build high-performing teams to offer the best care possible to their patients,' said NBMS president Dr. Lise Babin. She said she hopes the department will continue the investment in these clinical leaders. 'This is the quickest and most effective way to respond to our current access challenges, and if done right, we can achieve much more than 30 clinics in the coming years,' she said. — with files from Vicki Hogarth. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Miami Herald
26 minutes ago
- Miami Herald
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
LAS VEGAS, NEVADA / ACCESS Newswire / June 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the Company is in the final stages of prototyping its proprietary automated retinal camera. Ainnova's new device will offer users a low cost, easier to use camera that captures images automatically and then uploads those images to the Company's Vision AI software platform, which then produces a "risk report" in mere seconds. Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said, "The cost of a fundus camera has always been a barrier to entry into in this market, so our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market. "Another significant advantage will be that our camera will be seamlessly packaged together with our Vision AI platform, allowing us to refer more patients in less time and accurately to medical specialists. Also, one of our objectives is to integrate other technologies to this preventive screening, expanding the scope from only diabetic patients to patients who have other risk factors and want to prevent other diseases from a more complete approach." Vision AI is a powerful cutting-edge, AI-driven platform that can quickly and accurately detect the early markers of a host of diseases by applying AI models to examine imaging data from the eye to expedite earlier detection and allow patients to better manage their disease. The diseases that Vision AI can detect, include diabetic retinopathy, other retinopathies, such as glaucoma, macular edema, age-related macular degeneration, and other anomalies, as well as other diseases that do not require retinal images, and instead, use other datapoints that Ainnova has integrated into the software like the detection of cardiovascular disease (CVD), type 2 diabetes, liver fibrosis, and chronic kidney disease (CKD). Currently, Ainnova's Vision AI software works well with any fundus camera on the market; however, Ainnova and Avant are aiming for exclusivity by developing a lower-cost, easier to use camera. Ai-nova Acquisition Corp. (AAC), the company formed by the partnership between Avant and Ainnova, will develop the retinal cameras as part of the joint venture and licensing deal to facilitate the development of Ainnova's technology portfolio. AAC owns the global licensing rights to develop, maintain, and market Ainnova's technology portfolio. About Ainnova Tech, Inc. Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions. About Avant Technologies Inc. Avant Technologies Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about Avant can be found at You can also follow us on social media at: Forward-Looking Statements Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release. Contact: Avant Technologies SOURCE: Avant Solutions
Yahoo
36 minutes ago
- Yahoo
GraceMed announces appointment of Dan Pawliw as Chief Executive Officer
Dan Pawliw headshot TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- GraceMed, a leading consolidator in the plastic surgery, dermatology, and medical aesthetics industry, is pleased to announce the appointment of Dan Pawliw as its new Chief Executive Officer. A highly respected leader in clinical healthcare services, Dan brings a proven track record of innovation, growth, and team building. Over the past decade, he played a pivotal role in shaping and expanding Medcan, transforming it into one of Canada's most prominent health and wellness brands. He also co-founded Akira Health, a leading virtual healthcare services platform, which served millions of patients and was later acquired by Telus Health. He previously held roles in investment banking at Goldman Sachs in New York and JP Morgan H&Q in San Francisco. "Dan's leadership philosophy aligns with GraceMed's mission," said Dr. Douglas Grace, Founder and Chief Medical Officer of GraceMed. "His unwavering dedication to excellence in client care, forward-thinking approach to healthcare innovation, and deep appreciation for the incredible team behind it all will be instrumental in guiding GraceMed into its next chapter of growth." GraceMed seamlessly integrates cutting-edge technology with industry-leading procedures and best-in-class medical expertise. The team of highly skilled practitioners is committed to delivering personalized, high-quality care, ensuring exceptional results that help patients both look and feel their best. Dan joins GraceMed at a pivotal moment, as the company continues to evolve and redefine aesthetic, surgical, and functional medicine care across Canada. Dan Pawliw holds an MBA from Northwestern University and a Bachelor of Commerce from Queen's University. About GraceMedGraceMed is a North American-based platform helping more and more patients realize their true self. As a leading consolidator in the plastic surgery, dermatology and medical aesthetics industry, GraceMed partners with leading physicians and medical providers to deliver exceptional patient outcomes and results. For more information, visit Media contact:Dale GagoCommunications and Marketing Business PartnerFengate Asset 326 1473 A photo accompanying this announcement is available at: nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
